Phase II clinical and pharmacokinetic study of exatecan mesylate (DX-8951f) in patients with advanced ovarian cancer, refractory to, or relapsed after platinum and taxane P M Calvert,G C Jayson,R J Atkinson,T S Ganesan, A Cervantesruiperez,P A Vasey,M Adams,E Boven, A H Calvert, P ChevertonANNALS OF ONCOLOGY（2000）引用 1|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
